Skip to content
Migraine Science Collaborative
DONATE
Newsletter
Login
Register
Search
  • News & Opinion
    • News
    • Interviews
  • Literature Recap
    • Biweekly Lists
    • Editor’s Picks
    • Classic Papers
    • Original Research
    • Human Studies
    • Animal Studies
    • Reviews
    • Commentaries and editorials
  • Multimedia
    • Podcasts
    • Data Visualizations
    • Webinars
  • Professional Resources
    • Events Calendar
    • Grants
    • Community Announcements
    • Member Directory
    • MSC Announcements
    • MSC Travel Grants
    • MSC Early-Career Basic Science Contest
    • MSC Early-Career Clinical Research Contest
    • MSC Early-Career Science Library
  • About Us
    • About Us
    • FAQ
    • How to Cite
    • Editorial Board
    • Team
    • Supporters
    • For Patients
    • Donate
    • Contact Us
  • AMD
    • Medical Professional Resources
    • Migraine Symposium
    • Comorbidity Library
    • Spotlight on Migraine Podcast
    • AMD Blog
    • Shades for Migraine
Migraine Science Collaborative
Migraine Science Collaborative
Search
  • News
    • News
    • Interviews
  • Literature Recap
    • Biweekly Lists
    • Animal Studies
    • Classic Papers
    • Commentaries and editorials
    • Editor’s Picks
    • Human Studies
    • Original Research
    • Reviews
  • Multimedia
    • Podcasts
    • Data Visualizations
    • Webinars
  • Professional Resources
    • Events Calendar
    • Jobs
    • Grants
    • Community Announcements
    • Member Directory
    • Announcements
    • MSC Travel Grants
    • MSC Early-Career Basic Science Contest
    • MSC Early-Career Clinical Research Contest
    • Early-Career Science Library
  • About Us
    • FAQ
    • How to Cite
    • Editorial Board
    • Team
    • Supporters
    • For Patients
    • Contact Us
  • AMD
DONATE
Newsletter
Login or Register
  • Privacy Policy
  • Cookie Policy
  • Terms of Service
  • Sitemap

Posts Tagged ‘monoclonal antibody’

Zeroing in on PACAP to Treat Migraine

By Neil Andrews | October 31, 2024 | 0
Anti-PACAP antibody and migraine

A phase 2, placebo-controlled clinical trial found that an anti-PACAP antibody decreased monthly migraine days.

Read More

Recent Posts

  • Latest Call for Papers for the Jes Olesen Awards for the Advancement of Headache Medicine
  • Understanding the Full Burden of Headache Disorders: A Conversation with Andreas Husøy
  • Migraine Is Not One Disease, but Many: New Insight from a Machine Learning Study
  • Headache® Reviewers in Scientific Editing (RISE) Series Returns October 2026
  • 1st Annual Migraine Science Collaborative Early-Career Clinical Research Contest: Recording Now Available
Migraine Science Collaborative

News & Opinion

  • News
  • Interviews

Literature Recap

  • Editor’s Picks
  • Classic Papers
  • Original Research
  • Human Studies
  • Animal Studies
  • Reviews
  • Commentaries

Multimedia

  • Podcasts
  • Data Visualizations
  • Webinars

For Professionals

  • Events Calendar
  • Grants
  • Community Announcements
  • Member Directory
  • MSC Announcements
  • MSC Travel Grants
  • MSC Early-Career Basic Science Contest
  • MSC Early-Career Clinical Research Contest
  • MSC Early-Career Science Library

About MSC

  • About Us
  • FAQ
  • How to Cite
  • Editorial Board
  • Team
  • Supporters
  • For Patients
  • Donate
  • AMD

©2026 Migraine Science Collaborative. All Rights Reserved.

  • Privacy Policy
  • Cookie Policy
  • Terms of Service
  • Sitemap